Memantine Hydrochloride NDC 33342-297

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-297Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0297Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-297-09	33342029709	60 TABLET in 1 BOTTLE (33342-297-09)Marketed from Oct 13, 2015
33342-297-12	33342029712	10 BLISTER PACK in 1 CARTON (33342-297-12) / 10 TABLET in 1 BLISTER PACKMarketed from Oct 13, 2015
33342-297-15	33342029715	500 TABLET in 1 BOTTLE (33342-297-15)Marketed from Oct 13, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Memantine Hydrochloride
Generic name (nonproprietary): memantine hydrochloride
Active ingredients: Memantine hydrochloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202840
Marketing start: Oct 13, 2015
Listing expires: Dec 31, 2026
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 33342-297_672222e3-12b9-488f-a5ee-c47736d65cceSPL ID 672222e3-12b9-488f-a5ee-c47736d65cceSPL set ID 989fa756-7d70-4ea7-bb5e-f4395e48589dRxCUI 996561, 996571UNII JY0WD0UA60UPC 0333342297099, 0333342298096, 0333342298157
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342029709 followed by a unit qualifier and the quantity

Package 33342-0297-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 31, 2022.

Indications (excerpt from the label)

Memantine hydrochloride USP is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer's type. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202840

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202840
Product	Strength	Form · route	Labeler	Product NDC
Memantine Hydrochloride	Memantine hydrochloride 10 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-298
Memantine Hydrochloride	Memantine hydrochloride 10 mg/1	TabletOral	A-S Medication Solutions	50090-5832